Increasing Prevalence Of Asthma Fueling The Growth Of The Market Due To Rising Exposure To Air Pollution And Associated Health Risks Is Supporting Development Across The Asthma Therapeutics Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

By 2030, How Much Growth In Market Size Is Expected For The Asthma Therapeutics Market?

The asthma therapeutics market has experienced significant growth in recent years. It is projected to increase from $33.11 billion in 2025 to $35.73 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.9%. This historical growth can be linked to the limited availability of biologics, reliance on short-acting beta agonists, a rising global prevalence of asthma, an increase in hospital and specialty clinic visits, and the adoption of oral and inhaled medications.

The asthma therapeutics market size is projected to experience substantial expansion over the coming years. It is forecast to grow to $47.87 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.6%. The expansion during the forecast period is primarily driven by the development of novel biologics and combination therapies, the increasing adoption of telemedicine and digital health monitoring, rising awareness of preventive treatments, improved healthcare access in emerging markets, and growing investment in research and drug development. Key trends in this period include the increasing uptake of personalized asthma therapies, greater usage of inhalers and biologics, the expansion of homecare and remote monitoring solutions, a growing preference for combination inhalers, and an enhanced focus on pediatric and geriatric asthma care.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25702&type=smp

What Important Drivers Are Powering The Asthma Therapeutics Market Growth?

The rising occurrence of asthma is anticipated to drive the expansion of the asthma therapeutics market in the future. Asthma is defined as a chronic condition characterized by inflammation and swelling in the airways, leading to their constriction, which impairs the flow of air from the nose and mouth to the lungs. This growing prevalence of asthma stems from an increase in pollutants, which provoke irritation in the airways and elevate the likelihood of developing the illness. Asthma therapeutics assist in managing the condition by regulating inflammation in the airways, alleviating symptoms, and averting asthma attacks. For example, in May 2025, the UK Parliament, a UK-based government body, reported that 3,886,879 individuals aged over six were diagnosed with asthma in 2023-24, making up 6.5% of England’s population. Consequently, the escalating occurrence of asthma is fueling the expansion of the asthma therapeutics market.

How Is The Asthma Therapeutics Market Distributed Across Key Segments?

The asthma therapeutics market covered in this report is segmented –

1) By Drug Class: Inhaled Corticosteroids (ICS), Long-Acting Beta Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Short-Acting Beta Agonists (SABA), Biologics, Combination Inhalers (ICS + LABA)

2) By Treatment Stage: Acute Treatment, Long-Term Control, Preventive Treatment, Maintenance Regimens, Rescue Medications

3) By Route Of administration: Oral, Inhaled, Intravenous, Subcutaneous

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Homecare, Specialty Clinics

Subsegments:

1) By Inhaled Corticosteroids (ICS): Fluticasone, Budesonide, Beclomethasone, Mometasone, Ciclesonide

2) By Long-Acting Beta Agonists (LABA): Salmeterol, Formoterol, Indacaterol, Olodaterol

3) By Leukotriene Receptor Antagonists (LTRA): Montelukast, Zafirlukast, Pranlukast

4) By Short-Acting Beta Agonists (SABA): Albuterol (Salbutamol), Levalbuterol, Terbutaline

5) By Biologics: Omalizumab, Mepolizumab, Benralizumab, Dupilumab, Reslizumab

6) By Combination Inhalers (ICS + LABA): Fluticasone + Salmeterol, Budesonide + Formoterol, Mometasone + Indacaterol, Beclomethasone + Formoterol

Which Trends Are Guiding The Development Of The Asthma Therapeutics Market?

Leading companies within the asthma therapeutics market are concentrating on developing innovative solutions, such as anti-inflammatory rescue inhalers, to improve symptom relief, inflammation control, and overall disease management. An anti-inflammatory rescue inhaler is a dual-action therapeutic approach that combines a fast-acting bronchodilator with an inhaled corticosteroid in a single device, enabling rapid bronchodilation, on-demand inflammation reduction, and the prevention of severe asthma attacks. For instance, in January 2024, AstraZeneca plc, a UK-based biopharmaceutical company, introduced AIRSUPRA, an FDA-approved anti-inflammatory rescue inhaler specifically designed to provide immediate symptom alleviation along with swift anti-inflammatory action. It features as-needed dual-mechanism dosing, real-time suppression of airway inflammation, and support in averting exacerbation-related lung-function decline. AIRSUPRA enhances asthma control, diminishes the risk of severe attacks, and strengthens the overall effectiveness of rescue therapy.

Which Firms Are Competing In The Asthma Therapeutics Market?

Major companies operating in the asthma therapeutics market are Roche Holding AG, Merck & Co Inc., Pfizer Inc., AstraZeneca plc, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, Mylan N.V.

Access The Complete Asthma Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/asthma-therapeutics-global-market-report

Which Region Stands As The Largest Contributor To The Asthma Therapeutics Market?

North America was the largest region in the asthma therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Asthma Therapeutics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=25702&type=smp

Browse Through More Reports Similar to the Global Asthma Therapeutics Market 2026, By The Business Research Company

Asthma Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795